SCHEMBL7534006

SCHEMBL7534006

Fc1cc(F)c(Cl)cc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
CYP3A4 P08684 1/20 0.41
KDM1A O60341 2/20 0.41
MAPT P10636 2/20 0.41
KDM1B Q8NB78 1/20 0.41
MAPK1 P28482 2/20 0.39
AHR P35869 1/20 0.39
GPR84 Q9NQS5 1/20 0.38
MEN1 O00255 1/20 0.36
HTT P42858 1/20 0.36
KMT2A Q03164 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
ALPL P05186 3/20 0.35
HPGD P15428 3/20 0.35
TSHR P16473 3/20 0.35
HSD17B10 Q99714 3/20 0.35
CASP1 P29466 1/20 0.35
HTR2A P28223 1/20 0.33
HTR2C P28335 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL811929 0.89 KDM1A (0.44) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL7940907 0.89 AHR (0.44) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL29362089 0.89 KDM1A (0.44) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL23351729 0.88 KDM1A (0.48) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL23557091 0.81 ALDH1A1 (0.39) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL6951667 0.78 RAPGEF4 (0.38) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL23539570 0.78 KDM1A (0.48) ALDH1A1TDP1KDM1AMAPTKDM1B
SCHEMBL8492289 0.78 GAA (0.50) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL18129369 0.78 ALDH1A1 (0.38) ALDH1A1TDP1CYP3A4KDM1AMAPT
SCHEMBL12378577 0.78 ALDH1A1 (0.43) ALDH1A1TDP1KDM1AMAPTKDM1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0598338-B1 Process for the preparation of 1,3 - difluorbenzene HOECHST AG (DE) 1997-03-12 EP claimed
US-5504264-A REDUCTIVE DEHALOGENATION OF A 1,3-DIFLUOROCHLORO- OR BROMOBENZENE USING HYDROGEN, A PALLADIUM SUPPORTED CATALYST AND AN AMINE ACID ACCEPTOR HOECHST AKTIENGESELLSCHAFT (DE) 1996-04-02 US claimed
EP-0562435-B1 Process for the preparation of 3,5-difluoroaniline HOECHST AG (DE) 1995-06-07 EP claimed
EP-0598338-A1 Process for the preparation of 1,3 - difluorbenzene HOECHST AKTIENGESELLSCHAFT (DE) 1994-05-25 EP claimed
US-5294742-A Process for preparing 3,5-difluoroaniline HOECHST ATKIENGESELLSCHAFT (DE) 1994-03-15 US claimed
EP-0562435-A1 Process for the preparation of 3,5-difluoroaniline HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP claimed
EP-4719022-A2 NITROGEN-CONTAINING HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC Ireland Limited (IE) 2026-04-01 EP disclosed
US-20250185505-A1 NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2025-06-05 US disclosed
US-20250171684-A1 AROMATIC HETREOCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2025-05-29 US disclosed
WO-2023161168-A1 AROMATIC HETREOCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-08-31 WO disclosed
WO-2023161167-A1 NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2023-08-31 WO disclosed
WO-2016124139-A1 HETEROCYCLIC-SUBSTITUTED N-SULFONYLBENZAMIDE DERIVATIVES, PREPARATION METHOD FOR DERIVATIVES, AND PHARMACEUTICAL USE OF DERIVATIVES 上海海雁医药科技有限公司 2016-08-11 WO disclosed
EP-0878461-B1 Process for the preparation of 3,5-difluoroaniline CLARIANT GMBH (DE) 2002-04-10 EP disclosed
US-5504264-A REDUCTIVE DEHALOGENATION OF A 1,3-DIFLUOROCHLORO- OR BROMOBENZENE USING HYDROGEN, A PALLADIUM SUPPORTED CATALYST AND AN AMINE ACID ACCEPTOR HOECHST AKTIENGESELLSCHAFT (DE) 1996-04-02 US disclosed
EP-0562435-B1 Process for the preparation of 3,5-difluoroaniline HOECHST AG (DE) 1995-06-07 EP disclosed
EP-0598338-A1 Process for the preparation of 1,3 - difluorbenzene HOECHST AKTIENGESELLSCHAFT (DE) 1994-05-25 EP disclosed
US-5294742-A Process for preparing 3,5-difluoroaniline HOECHST ATKIENGESELLSCHAFT (DE) 1994-03-15 US disclosed
US-5294742-A Process for preparing 3,5-difluoroaniline HOECHST ATKIENGESELLSCHAFT (DE) 1994-03-15 US disclosed
EP-0562435-A1 Process for the preparation of 3,5-difluoroaniline HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed
EP-0562435-A1 Process for the preparation of 3,5-difluoroaniline HOECHST AKTIENGESELLSCHAFT (DE) 1993-09-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250171684-A1 AROMATIC HETREOCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES AHR, PAH, DDT ALDH1A1 1102/4885TDP1 2684/4885CYP3A4 226/4885
US-20250185505-A1 NITROGENOUS HETEROCYCLES FOR ORGANIC ELECTROLUMINESCENT DEVICES NES, NUDC, HCN2 ALDH1A1 2145/4885TDP1 2341/4885CYP3A4 1291/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.